The stages of PRP healing

If you have recently undergone Platelet-Rich Plasma (PRP) therapy or are considering it, you may be wondering about the next steps. Healing after regenerative treatments like PRP does not happen quickly. It kickstarts your body’s natural healing process, and knowing the stages of recovery can help you manage your expectations and optimize your outcome.

Whether you are dealing with joint pain, tendon injuries, or other musculoskeletal conditions, understanding how your body reacts to PRP therapy can empower you on your healing journey.

What is PRP? Understanding the PRP Healing Stages and Process

PRP therapy is a regenerative approach that uses the body’s own healing abilities to repair damaged tissues and alleviate pain. A small blood sample is taken, spun in a centrifuge to concentrate the platelets, and then injected into the injured area to stimulate tissue regeneration. Common areas for PRP injections include the hip, shoulder, knee, elbow, spine, and extremities.

Healing with PRP therapy occurs in three stages. In the first stage, inflammation and soreness are common as the body begins the repair process. The second stage sees the formation of new tissue, reducing pain and enhancing function. By the third and final stage, many patients start feeling significant improvement, although full benefits may take longer to manifest.

Stage 1 – Inflammatory Phase (0-7 Days)

When PRP is injected, concentrated platelets release growth factors and signaling proteins that attract cells like white blood cells and stem cells. Patients may experience temporary inflammation and discomfort in the first week post-treatment due to the body’s response to the treatment resembling an acute injury.

Other symptoms often observed during this healing phase include mild to moderate pain, swelling, warmth, stiffness, mild bruising, and tenderness to the touch. These symptoms are usually mild and resolve within a few days to a week.

Stage 2 – Proliferative Phase (1-4 Weeks)

In the weeks following PRP therapy, platelets release growth factors that stimulate tissue repair, collagen production, and stem cell activity, leading to noticeable pain relief and improved function. Incorporating physical therapy during this time can further boost the healing process. Stretching, mobility exercises, strength training, and low-impact activities can aid in circulation, prevent stiffness, and provide support to the tissues.

Stage 3 – Remodeling Phase (4-12 Weeks)

Around four weeks after PRP therapy, the healing process transitions from regeneration to strengthening. The newly formed collagen and repaired tissue mature, becoming more structured and resilient. In the ensuing months, inflammation decreases, the treated area strengthens, and there is improved stability and function. Most patients experience significant pain relief, enhanced mobility, and can gradually return to normal activities.

When to Expect Full PRP Therapy Results

The optimal benefits of PRP therapy are typically seen between three and six months post-treatment. Complete healing is indicated by reduced pain and discomfort, improved mobility and flexibility, stronger tissue, reduced inflammation and swelling, and an enhanced ability to resume activities. Your doctor will devise the best treatment plan based on your progress.

Trust the Process with Desert Spine and Sports Physicians

PRP therapy is a natural means to aid tissue healing, alleviate pain, and restore function. While recovery occurs in stages, most patients experience substantial improvement within weeks of treatment. If you are struggling with joint pain or musculoskeletal conditions, our team of physiatrists can assist you in devising a tailored treatment plan.

Osteoarthritis (OA) is the most widespread form of arthritis.

Comprehensive Care for Bunions and Hammertoes: Insights into Early Signs, Prevention Strategies, and Treatment Options

Bunions and hammertoes are common foot conditions that can.

Latest Advances in Achilles Tendinitis Treatment: A Deep Dive into Modern Treatment Options, Including Non-Invasive Techniques

Achilles tendonitis is a common issue that affects both.

Managing Foot and Ankle Fractures: Tips on Immediate Actions Post-Injury, Recovery Processes, and Long-Term Care Strategies

Foot and ankle fractures can significantly impact your mobility.

Nutrition and Supplements for Healing Meniscus Tears: Fact vs. Fiction

Navigating the healing process after a meniscus tear can.

Platelet-rich plasma (PRP) therapy is a regenerative treatment that promotes tissue repair and natural healing responses. Derived from a sample of your blood, PRP avoids risks associated with long-term pain medications. Dr. Dominique Nickson at Next Step Orthopedics uses PRP injections to treat various orthopedic issues, reducing painful symptoms and restoring function.

PRP and the healing process

Platelets contain growth factors crucial for healing and tissue repair. PRP supports the healing phases of inflammation, proliferation, and remodeling, enhancing each stage.

Inflammation

Inflammation initiates healing by fighting infections and activating immune responses. Clotting controls bleeding associated with certain injuries.

Proliferation

Damaged tissues are replaced by healthy cells supported by growth factors in PRP that stimulate cell recruitment, collagen production, and new blood vessel formation for nutrients delivery and waste removal.

Remodeling

Collagen formation in the final phase repairs damaged areas and prevents future injuries through dense scar tissue creation. PRP therapy provides additional growth factors to enhance responses in each healing stage.

Where PRP is used

PRP therapy is ideal for various orthopedic issues like knee arthritis, tendonitis, and rotator cuff tears. In addition to injections, PRP can be used during arthroscopic surgery to jump-start healing postoperatively.

PRP treatment

PRP treatment starts with blood extraction, processing in a centrifuge to separate platelets and plasma, and reinjection into the injury site. The entire treatment process is performed in-office, and minor swelling and discomfort post-injection are expected. Strenuous activities may need to be limited initially. Most activities can resume within a week.

Find out if PRP is right for you

In orthopedic injuries, PRP is important but not always appropriate. Dr. Nickson at Next Step Orthopedics evaluates your condition before recommending PRP or any therapy to tailor treatment to your needs and goals.

If you want to learn more about PRP and its role in treatment, call us at (972) 547-0047 or book an appointment online.

Your pain has been debilitating and unresponsive to traditional care. Athletes have lauded PRP. What is PRP? Are there different types? What is the injection process? PRP indications? Recovery duration? Let’s delve into it.

What is PRP?

PRP, or Platelet-Rich Plasma, contains growth factors that assist in healing. It is a concentration of a patient’s platelets in plasma to accelerate healing.

Are There Different Types of PRP?

There are two main types of PRP used for injection based on the presence of red and white blood cells.

• Red PRP is rich in cells, known as leukocyte rich (LR-PRP)
• Amber PRP has low quantities of cells, known as leukocyte poor (LP-PRP)

PRP Injection Process

The PRP injection process entails drawing blood, centrifuging it, customizing PRP concentration, and injecting it into a target area using image guidance.

1. Blood drawn
2. Centrifuge used to separate blood
3. Injection with guidance
4. Recovery time discussed

To learn more, watch the video about PRP.

Indications for PRP

PRP can heal, alleviate pain, and enhance function in various conditions such as sciatica, knee arthritis, tennis elbow, Achilles tendinopathy, low back pain, and more.

• Achilles Tendinopathy
• Rotator Cuff Injuries
• Tennis Elbow
• Nerve Injuries

PRP Injection Recovery Time

PRP injection recovery time varies based on the treated area and severity of the condition. Recovery time can be influenced by injection site, injury severity, and number of injections.

Tendon and ligament healing occurs in three phases. Inflammation is the first, tissue rebuilding is the second, and tissue strengthening is the third.

Watch the video to learn more about ligament and tendon healing after PRP.

In Conclusion

PRP accelerates healing using concentrated platelets. It is an effective treatment for common orthopedic conditions, allowing patients to avoid surgical risks and complications.

Schedule a Telemedicine consultation with a physician to explore PRP as a treatment option.

John Schultz, MD

Dr. Schultz specializes in Interventional Orthopedics and bone marrow treatment for orthopedic injuries, offering non-surgical options.

Abstract

Musculoskeletal injuries cause severe, long-term pain and disability for millions globally. Platelet rich plasma (PRP) is a popular method in orthopaedic surgery and sports medicine to promote healing, containing growth factors in platelets. PRP aids in healing sports-related injuries to muscles, tendons, and ligaments. Though widely used, the clinical effectiveness and mechanisms of PRP are still under study.
The World Health Organization states that musculoskeletal injuries are the leading cause of long-term pain and disability globally. Orthopaedic surgeons strive for a safe recovery and quick return to pre-injury activities. Conventional treatment methods for injuries include conservative approaches, corticosteroid injections, and surgical interventions. Recent advancements in biotechnology have paved the way for the utilization of cell therapy and autologous blood products like PRP to enhance healing.
Platelets have a history of being used in managing blood disorders, while other blood components like fibrin have found their place in surgical procedures. PRP therapy has become popular due to its safety and simplicity, although its efficacy is still under investigation. Research indicates that PRP releases various growth factors that assist in healing soft tissue injuries.
Understanding the role of growth factors and their impact on cells is crucial in comprehending how PRP functions. Platelet injections trigger the release of growth factors that promote the healing process. The healing process involves stages such as hemostasis, inflammation, cellular proliferation, and wound remodeling.
Both acute and chronic sports-related injuries have distinct origins but follow a similar healing path. Grasping the interplay between key mediators during healing is vital for effective treatment. The healing phases encompass hemostasis, inflammation, cellular proliferation, and wound remodeling.
After an injury, capillary leakage allows for the recruitment of hemostatic factors and inflammatory mediators, initiating the coagulation cascade leading to platelet aggregation, clot formation, and the formation of a provisional extracellular matrix structure. Platelets bind to exposed collagen, prompting the release of bioactive substances like growth factors from alpha granules, such as cytokines, chemokines, and pro-inflammatory mediators.
During the inflammatory phase, chemoattractant substances call for neutrophils to the site of injury within 1-2 hours, with macrophages following suit around 48-72 hours post-injury to assist in debridement and inflammation regulation. Fibroblasts and endothelial cells are also recruited, with lymphocytes joining in the late inflammatory phase.
The phase of cellular and matrix proliferation is crucial for tissue repair and involves recruiting fibroblasts and epithelial cells to the injury site through pluripotent progenitor cells. Fibroblasts aid in collagen synthesis, wound contraction, and promote the formation of new tissue and blood vessels.
Wound maturation and remodeling entail the involvement of growth factors like PDGF and TGF-β, stimulating fibroblasts to synthesize components of the extracellular matrix. Collagen remodeling occurs to create a sturdy matrix during the maturation phase. Unfavorable environmental conditions can affect wound healing, and PRP has demonstrated its potential as a therapeutic option for soft tissue injuries.
PRP, or platelet-rich plasma, is a concentrated form of human platelets containing high levels of growth factors crucial for wound healing. While PRP therapy has shown positive outcomes in various surgical fields, its effectiveness in managing sports-related injuries remains a topic of debate.
The production of PRP involves spinning blood to isolate a platelet-rich fraction that can be injected directly into the injury site or used in surgical settings with biomaterials. Various protocols for PRP preparation exist, impacting platelet and growth factor concentrations. The quality and efficacy of PRP therapy can be affected by differences in commercial systems and protocols.
Further diversity in PRP products arises from patient variances in age, underlying medical conditions (especially blood disorders), and healing potential. The effects of PRP can differ based on individual characteristics and the concentration of platelet concentrates, leading to a range of outcomes in literature studies.
PRP is commonly utilized for treating sports-related injuries in orthopaedic practice involving muscles, tendons, and ligaments. It exerts its effects through the release of growth factors and other bioactive substances from alpha granules. The efficacy of PRP therapy may vary depending on the injury site and the concentration of growth factors.
Muscle injuries in sports, often characterized by contusions and strains, are prevalent. Muscle healing is typically slow and incomplete, leading to scarring and fibrosis that hinder full recovery. Modulation of fibrosis is a primary target of PRP therapy for muscle injuries.
Studies have evidenced that PRP can reduce fibrosis and enhance angiogenesis during muscle healing. Combining treatment with Losartan can further impede fibrosis development, boost angiogenesis, and enhance muscle strength in animal models.
Research has shown that PRP treatment can enhance muscle regeneration compared to conventional treatments in laboratory settings. Key growth factors such as IGF-1, FGF-2, HGF, and TGFβ-1 play vital roles in muscle regeneration and satellite cell activation post-PRP therapy.
Tendon injuries are a common occurrence in athletes, involving degeneration, ruptures, and retraction. The lengthy healing process may result in mechanically weakened scar tissue, increasing the risk of re-injury. Traditional treatments for tendon injuries include anti-inflammatory medications, corticosteroids, and local anesthetics, but their efficacy remains uncertain. Recent studies have shifted focus towards PRP for tendon injuries.
PRP has been shown to stimulate cell growth, collagen production, and differentiation of stem cells into active tenocytes. Additionally, PRP triggers the production of VEGF and HFG, contributing to angiogenesis and the formation of new blood vessels. Nonetheless, excessive angiogenesis may impede tendon healing by altering the properties of the extracellular matrix and increasing the expression of matrix metalloproteinases.
HGF, a growth factor released from activated platelets, aids in cell proliferation, anti-inflammatory effects, and modulation of cytokines. PRP may enhance tendon healing by boosting vascularity, reducing inflammation, and alleviating pain.
Ligament injuries, such as ACL tears, typically require surgical reconstruction due to their poor natural healing capacity. Autologous blood products like PRP have been utilized to accelerate ligament healing and facilitate a return to activity. VEGF is crucial in healing processes by promoting angiogenesis.
Studies on the role of VEGF in MCL healing demonstrate that supplemental VEGF enhances biomechanical strength, while the inhibition of VEGF delays repair. This underscores the significance of regulating growth factors for optimal healing outcomes.
PRP triggers the aggregation of inflammatory cells through the release of growth factors from activated platelets. In MCL injuries, PRP aids in recruiting pro-inflammatory cells like macrophages. M1 macrophages clear debris and release pro-inflammatory cytokines, while M2 macrophages contribute to scar tissue formation by releasing anti-inflammatory cytokines. Both phenotypes assist in ligament healing by controlling angiogenesis, fibroblast differentiation, and collagen production. In ACL reconstruction, inhibiting macrophages at the bone-tendon junction has been shown to enhance healing. Disparities in healing capacities likely play a role in these conclusions.
PRP has been leveraged to promote healing in animal models of ACL repair and reconstruction. Treatment with collagen-PRP hydrogel improved biomechanical features in a porcine model and enhanced the filling of ACL wound sites in a canine model. The collagen-PRP scaffold encourages the invasion of fibroblasts and endothelial cells, mirroring the function of a natural clot.
Ongoing studies are examining the impact of PRP on the outcomes of ACL reconstruction. Platelet compositions in collagen scaffolds have been found to reduce knee laxity in a caprine model. Growth factors released by platelets play a vital role in tissue healing, promoting the migration and proliferation of ACL cells.
Future research should focus on determining the optimal dosage, timing, and delivery methods for PRP. Standardizing platelet concentrations and evaluating delivery techniques over injured tissues are critical areas for further investigation. Patient-specific characteristics influence the quality of PRP and healing responses, underscoring the need for standardization in preparation and dosing for meaningful outcomes in orthopaedic care.
Another key aspect to consider in PRP research is identifying the ideal platelet count or growth factor concentration. While higher platelet counts have been associated with greater ACL graft strength, more platelets and growth factors may not always translate to improved outcomes. Research using a porcine model to study the optimal platelet concentration in PRP found that increasing the concentration did not significantly impact the results of primary ACL repair. Biomechanical outcomes were similar between PRP with 5x and 3x baseline platelet counts, despite histological differences. Although the 5x group showed improvements in cell density, collagen structure, and fibroblast morphology, the biomechanical outcomes were comparable, suggesting a disconnection between histology and clinical implications. Previous animal studies have suggested that increased cellularity early in wound healing can benefit ligaments and tendons, but these findings have been inconsistent.

Studies on the potential risks of platelet-rich plasma (PRP) are sparse, and further investigations are needed to assess the safety of autologous products. The process of preparing PRP and the possible distribution of platelets throughout the body present safety concerns, especially when additional substances like growth factors and platelet activators are used, indicating the necessity for more in-depth research in this field.

Conclusion

Due to variations in platelet content and growth factor levels in PRP, there is no singular mode of action. However, it is established that activated platelets release various growth factors that exert pro-inflammatory and anti-inflammatory effects on nearby cells. These effects are influenced by factors such as the stage of healing, the location of injury, and the cellular context. Ongoing research aims to unravel the interactions of individual growth factors and their impact. While basic scientific studies advocate for the use of PRP in sports-related injuries, clinical evidence remains insufficient, underscoring the urgency for further research to bridge this gap.

References

• Woolf A. D., Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81:646, 656. [PMC free article] [PubMed] [Google Scholar]
• Daly P. A., Schiffer C. A., Aisner J., Wiernik P. H. Platelet transfusion therapy. One-hour posttransfusion increments valuable in predicting need for HLA-matched preparations. Jama. 1980;243:435, 438. doi: 10.1001/jama.243.5.435. [DOI] [PubMed] [Google Scholar]
• Gardner F. Use of platelet transfusions. Br J Haematol. 1974;27:537–542. doi: 10.1111/j.1365-2141.1974.tb06618.x. [DOI] [PubMed] [Google Scholar]
• Blume M., Lauschke G. [Animal experiment effectiveness studies of fibrin glue in Achilles tendon injuries] Beitr Orthop Traumatol. 1987;34:309–312. [PubMed] [Google Scholar]
• Frykman E., Jacobsson S., Widenfalk B. Fibrin sealant in preventing flexor tendon adhesions: an experimental rabbit study. J Hand Surg Am. 1993;18:68–75. doi: 10.1016/0363-5023(93)90248-2. [DOI] [PubMed] [Google Scholar]

• Overview of wound healing
• Growth factors for rotator cuff repair
• Platelet-rich plasma in diabetic foot ulcers
• Biology
• Tissue repair and extracellular matrix dynamics
• Tendon stem cell differentiation
• Pathogenesis of tendinopathy
• Antibacterial effect of platelet gel
• Autologous blood injection for tennis elbow
• Platelet concentrate for Achilles tendon repair
• Platelet rich plasma in sports medicine
• Plasma rich in growth factors for implant preparation
• Platelet gel for oral and maxillofacial surgery
• Stimulation of repair in cutaneous ulcers using platelet-derived wound healing formula
• Tissue adhesive in facial plastic and reconstructive surgery
• Autologous fibrin glue for incision closure
• Platelet-rich plasma in oral surgery
• Comparison of platelet concentration in commercial plasma separation systems
• VEGF in circulating blood
• Antimicrobial activity of platelet-leukocyte gel
• Current treatment options for muscle contusion injuries
• Optimizing recovery in muscle injuries
• Analysis of changes in mRNA levels in healing skeletal muscle
• Ultrastructural and immunohistochemical study of muscle injury healing
• Management of muscle strain injuries
• Enhancement of muscle healing through prevention of fibrosis
• Interaction between macrophages and the COX-2 pathway in skeletal muscle healing
• Regulation of extracellular matrix proteoglycan gene expression
• Association of latent transforming growth factor-beta 1 to fibroblast extracellular matrix
• Differentiation of myogenic cells into fibrotic cells in injured skeletal muscle
• Transforming growth factor beta in tissue fibrosis
• Combination treatment of platelet-rich plasma and angiotensin II receptor blocker for muscle injury in mice
• Improved muscle regeneration and decreased fibrosis with angiotensin II receptor blockade
• Platelet-rich plasma to treat muscle strain injuries
• Local administration of autologous conditioned serum for muscle injuries
• Treatment of muscle injuries with autologous conditioned serum in sportsmen
• Growth factors for muscle healing

• Lefaucheur J. P., Sebille A. Muscle regeneration following injury can be modified by immune neutralization of basic fibroblast growth factor, transforming growth factor beta 1, or insulinlike growth factor I.
• Allen R. E., Sheehan S. M., Taylor R. G. Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro.
• Maffulli N., Khan K. M., Puddu G. Overuse tendon conditions: time to change confusing terminology.
• Coombes B. K., Bisset L., Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for tendinopathy management: a systematic review of randomized controlled trials.
• Magra M., Maffulli N. Nonsteroidal anti-inflammatory drugs in tendinopathy: friend or foe?
• Maffulli N., Longo U. G., Denaro V. Novel approaches for tendinopathy management.
• Mikolyzk D. K., Wei A. S., Tonino P., Marra G., Williams D. A., Himes R. D., Wezeman F. H., Callaci J. J. Corticosteroids effect on the biomechanical strength of rat rotator cuff tendon.
• Gialanella B., Prometti P. Corticosteroids injection effects in rotator cuff tears.
• Mishra A., Woodall J., Jr., Vieira A. Treatment of tendon and muscle using platelet-rich plasma.
• Geng Z., Wang C., Zhou H. Platelet-rich plasma effect on tendon healing.

Indomethacin and celecoxib impair rotator cuff tendon-to-bone healing. doi: 10.1177/0363546505280428
Correlation of healing capacity with vascular response in ligaments of the rabbit. doi: 10.1016/S0736-0266(03)00078-0
Characterization of the intrinsic properties of ligament cells: an in vitro cell culture study. doi: 10.1002/jor.1100100402
Procollagen gene expression in healing of ligaments in rabbits. doi: 10.1002/jor.1100090309
Intrinsic properties of ligament cells and their responses to growth factors. Med Sci Sports Exerc. 1995;27:844–851
Applications of platelet-rich plasma in musculoskeletal and sports medicine. doi: 10.1016/j.pmrj.2010.11.007
Assessment of blood flow to knee ligaments in rabbits: effects of injury. doi: 10.1002/jor.1100140417
Fine vascular anatomy of knee ligaments. J Anat. 1990;172:69–79
Molecular mechanisms of tumor metastasis and angiogenesis. doi: 10.1007/s004230050183
Tenomodulin is necessary for tenocyte proliferation and tendon maturation. doi: 10.1128/MCB.25.2.699-705.2005
Vascular endothelial growth factor is more important than basic fibroblastic growth factor during ischemic wound healing. doi: 10.1001/archsurg.134.2.200
Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. doi: 10.1038/ncb1008
Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. doi: 10.1083/jcb.150.5.1085
Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. doi: 10.1083/jcb.200108150
Role of angiogenesis after muscle-derived stem cell transplantation in injured medial collateral ligament. doi: 10.1002/jor.21551
Spatio-temporal dynamics of ligament healing. doi: 10.1111/j.1524-475X.2009.00465.x
The role of macrophages in early healing of a tendon graft in a bone tunnel. doi: 10.2106/JBJS.F.00531
Collagen-platelet rich plasma hydrogel enhances primary repair of the anterior cruciate ligament. doi: 10.1002/jor.20282
Enhanced histologic repair in a wound in the anterior cruciate ligament with a collagen-platelet-rich plasma scaffold. doi: 10.1002/jor.20367
Fibroblast chemotaxis after tendon repair. J Hand Surg Am. 1991;16:686–693
Use of platelets to affect functional healing of an anterior cruciate ligament (ACL) autograft in a caprine ACL reconstruction model. doi: 10.1002/jor.20785
Roles of growth factors in tendon and ligament healing. doi: 10.2165/00007256-200333050-00004
Effect of selected growth factors on human anterior cruciate ligament cell interactions with a three-dimensional collagen-GAG scaffold. doi: 10.1016/S0736-0266(02)00142-0
Efficacy of autologous platelet-rich plasma use for orthopaedic indications: a meta-analysis. doi: 10.2106/JBJS.K.00154
Effects of age and platelet-rich plasma on ACL cell viability and collagen gene expression. doi: 10.1002/jor.21496
Reduced platelet concentration does not harm PRP effectiveness for ACL repair in a porcine in vivo model. doi: 10.1002/jor.21375
Expression of collagen and matrix metalloproteinases in ruptured human anterior cruciate ligament: an in situ hybridization study. doi: 10.1002/jor.1100140603
Growth factor expression in healing rabbit medial collateral and anterior cruciate ligaments. Iowa Orthop J. 1998;18:19–25
Tendons and ligaments: a morphological and biochemical comparison. doi: 10.1002/jor.1100010305
Changes in mRNA in uninjured ligaments of the knee. doi: 10.1007/s00776-003-0695-x